日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

内皮细胞 pY397-FAK 表达可预测 SweBCG91-RT 队列中乳腺癌放疗后复发的风险

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2939
Drake Rebecca J G, Landén Amalia H, Holmberg Erik, Stenmark Tullberg Axel, Killander Fredrika, Niméus Emma, Jordan Alexander, McGuinness Jennifer, Karlsson Per, Hodivala-Dilke Kairbaan
细胞生物学
FAK
肿瘤免疫
发表日期：2025
文献求助 收藏

Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer

低风险乳腺癌保乳手术后省略术后放疗

期刊:Jnci-Journal of the National Cancer Institute
影响因子:7.2
doi:10.1093/jnci/djae315
Palmér, Sofia; Valachis, Antonis; Lindman, Henrik; Smith, Daniel Robert; Wickberg, Åsa; Killander, Fredrika; Bjöhle, Judith; Einbeigi, Zakaria; Nilsson, Greger; Ahlgren, Johan; Villman, Kenneth
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer

原发性三阴性乳腺癌的独立转录组免疫反应预测

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-25-0453
Roostee, Suze; Killander, Fredrika; Saghir, Hani; Nacer, Deborah F; Häkkinen, Jari; Sasiain, Iñaki; Veerla, Srinivas; Vallon-Christersson, Johan; Loman, Niklas; Ohlsson, Mattias; Staaf, Johan
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohort

评估SP142和22C3免疫组化PD-L1表达在三阴性乳腺癌中的替代预后阈值：一项基于人群队列的研究结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-024-07561-x
Sigurjonsdottir, Gudbjörg; De Marchi, Tommaso; Ehinger, Anna; Hartman, Johan; Ullén, Susann; Leandersson, Karin; Bosch, Ana; Staaf, Johan; Killander, Fredrika; Niméus, Emma
肿瘤
IHC
肿瘤免疫
乳腺癌
PD-L1
SP1
免疫/内分泌
发表日期：2025
文献求助 收藏

Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial

肿瘤 pSMAD2 作为早期乳腺癌的预后生物标志物：来自随机 SweBCG91RT 试验的启示

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-025-07744-0
Stenmark Tullberg, Axel; Thurfjell, Viktoria; Kovács, Anikó; Micke, Patrick; Moustakas, Aristidis; Killander, Fredrika; Niméus, Emma; Holmberg, Erik; Karlsson, Per; Strell, Carina
SMAD2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE

曲妥珠单抗德鲁替康联合生物学驱动的新辅助治疗方案选择在HER2阳性乳腺癌中的随机对照试验：ARIADNE研究方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-102626
Matikas, Alexios; Naume, Bjørn; Wildiers, Hans; Sonke, Gabe; Dieci, Maria Vittoria; Karakatsanis, Andreas; Andersson, Anne; Barnekow, Elin; Kessler, Luisa Edman; Einbeigi, Zakaria; Killander, Fredrika; Linderholm, Barbro; Schiza, Aglaia; Valachis, Antonis; Nearchou, Andreas; Engebraaten, Olav; Porojnicu, Alina; Soland, Mari Hiorth; Mannsåker, Bård; Raj, Sunil X; Blix, Egil Støre; Nordstrand, Cecilie Soma; Lambertini, Matteo; Vernieri, Claudio; Punie, Kevin; Sotiriou, Christos; Bergh, Jonas; Villacampa, Guillermo; Zouzos, Athanasios; Hellström, Mats; Hartman, Johan; Foukakis, Theodoros
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial

结合组织学分级、肿瘤浸润淋巴细胞（TILs）和PD-1/PD-L1通路来识别免疫原性肿瘤并降低早期乳腺癌的放疗强度：一项随机临床试验的二次分析

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-006618
Stenmark Tullberg, Axel; Sjöström, Martin; Tran, Lena; Niméus, Emma; Killander, Fredrika; Kovács, Anikó; Lundstedt, Dan; Holmberg, Erik; Karlsson, Per
肿瘤
肿瘤免疫
信号转导
乳腺癌
PD-L1
细胞生物学
PD-1
免疫/内分泌
发表日期：2023
文献求助 收藏

Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial

整合肿瘤内在因素和免疫因素以从低风险人群中识别免疫原性乳腺癌：来自随机SweBCG91RT试验的结果

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2746
Stenmark Tullberg, Axel; Sjöström, Martin; Niméus, Emma; Killander, Fredrika; Chang, S Laura; Feng, Felix Y; Speers, Corey W; Pierce, Lori J; Kovács, Anikó; Lundstedt, Dan; Holmberg, Erik; Karlsson, Per
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏

Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms

在基于人群的三阴性乳腺癌患者队列中，结合临床已建立的评分算法，对 SP142 和 22C3 PD-L1 检测方法进行比较

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-023-01724-2
Sigurjonsdottir, Gudbjörg; De Marchi, Tommaso; Ehinger, Anna; Hartman, Johan; Bosch, Ana; Staaf, Johan; Killander, Fredrika; Niméus, Emma
肿瘤
肿瘤免疫
乳腺癌
PD-L1
SP1
发表日期：2023
文献求助 收藏

Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up

一项大型随机试验，长期随访研究了乳腺癌乏氧与保乳手术后预后及放疗获益的关系

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-021-01630-4
Tutzauer, Julia; Sjöström, Martin; Holmberg, Erik; Karlsson, Per; Killander, Fredrika; Leeb-Lundberg, L M Fredrik; Malmström, Per; Niméus, Emma; Fernö, Mårten; Jögi, Annika
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏